John Bentivoglio is a partner in the firm’s Washington, D.C., office and serves as Co-Chair of the FDA/Healthcare Group. His practice focuses on assisting pharmaceutical, medical device, and biotechnology manufacturers in three broad areas: FDA and healthcare regulatory counseling, compliance program development and implementation, and representation of companies in civil and criminal investigations by federal and state law enforcement agencies. On the regulatory side, he advises companies on federal and state anti-kickback laws, FDA advertising and promotional rules, drug pricing and reporting, and Medicare reimbursement issues. He has assisted numerous companies in developing, implementing and assessing corporate compliance programs in line with U.S. Sentencing Commission and HHS Office of Inspector General Guidelines, and with state compliance program laws and regulations. And he has represented pharmaceutical and medical device manufacturers in investigations by U.S. Attorney’s Offices in Massachusetts, New York, Maryland, and California.